Garde Capital »

Nautilus Biotechnology shares owned by Garde Capital

Quarter-by-quarter ownership of Nautilus Biotechnology (NAUT) shares owned by Garde Capital from 13F filings

Historical chart of Garde Capital investment in Nautilus Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Nautilus Biotechnology held by Garde Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nautilus Biotechnology by Garde Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $35k 18k 1.95

More positions owned by Garde Capital

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Large Cap Etf (VV)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Microsoft Corporation (MSFT)
Vanguard Intl Equity Index F Ftse Pacific Etf (VPL)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Vanguard Index Fds Small Cp Etf (VB)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Real Estate Etf (VNQ)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)

View all positions for Garde Capital

Top funds holding Nautilus Biotechnology

AH Capital Management
Perceptive Advisors
Cercano Management
Madrona Venture Group
Vanguard Group
Comprehensive Financial Management
Amazon
Clarius
Millennium Management
_Sentinel Trust Company, LBA______________
Tikvah Management
Acadian Asset Management
Geode Capital Management
Goldman Sachs Group
Dimensional Fund Advisors

View all funds holding Nautilus Biotechnology